Revisiting Platinum-Based Anticancer Drugs to Overcome Gliomas

Revisiting Platinum-Based Anticancer Drugs to Overcome Gliomas

Although there are many patients with brain tumors worldwide, there are numerous difficulties in overcoming brain tumors. Among brain tumors, glioblastoma, with a 5-year survival rate of 5.1%, is the most malignant. In addition to surgical operations, chemotherapy and radiotherapy are generally perf...

Full description

Bibliographic Details
Main Authors:	Jaewan Jeon, Sungmin Lee, Hyunwoo Kim, Hyunkoo Kang, HyeSook Youn, Sunmi Jo, BuHyun Youn, Hae Yu Kim
Format:	Article
Language:	English
Published:	MDPI AG 2021-05-01
Series:	International Journal of Molecular Sciences
Subjects:	platinum-based anticancer drugs brain tumors drug resistance therapeutic efficacy
Online Access:	https://www.mdpi.com/1422-0067/22/10/5111

Similar Items

Monofunctional Platinum(II) Anticancer Agents
by: Suxing Jin, et al.
Published: (2021-02-01)

Photoactivatable Platinum-Based Anticancer Drugs: Mode of Photoactivation and Mechanism of Action
by: Ziwen Dai, et al.
Published: (2020-11-01)

Synthesis and Characterisation of Platinum(II) Diaminocyclohexane Complexes with Pyridine Derivatives as Anticancer Agents
by: Brondwyn S. McGhie, et al.
Published: (2023-12-01)

Research Progress of Metal Anticancer Drugs
by: Yun Bai, et al.
Published: (2023-12-01)

The Protein-Binding Behavior of Platinum Anticancer Drugs in Blood Revealed by Mass Spectrometry
by: Jingchen Wang, et al.
Published: (2021-01-01)

Combination of Drug Delivery Properties of PAMAM Dendrimers and Cytotoxicity of Platinum(IV) Complexes—A More Selective Anticancer Treatment?
by: Yvonne Lerchbammer-Kreith, et al.
Published: (2023-05-01)

Platinum(IV)-Loaded Degraded Glycol Chitosan as Efficient Platinum(IV) Drug Delivery Platform
by: Yvonne Lerchbammer-Kreith, et al.
Published: (2023-03-01)

Quaternary Ammonium Palmitoyl Glycol Chitosan (GCPQ) Loaded with Platinum-Based Anticancer Agents—A Novel Polymer Formulation for Anticancer Therapy
by: Yvonne Lerchbammer-Kreith, et al.
Published: (2023-07-01)

Nanoparticles Loaded with Platinum Drugs for Colorectal Cancer Therapy
by: Buhle Buyana, et al.
Published: (2022-09-01)

Palladium and Platinum Complexes of the Antimetabolite Fludarabine with Vastly Enhanced Selectivity for Tumour over Non-Malignant Cells
by: Sebastian W. Schleser, et al.
Published: (2023-07-01)

BEX1 and BEX4 Induce GBM Progression through Regulation of Actin Polymerization and Activation of YAP/TAZ Signaling
by: Sungmin Lee, et al.
Published: (2021-09-01)

Decreased Hepatic Lactotransferrin Induces Hepatic Steatosis in Chronic Non-Alcoholic Fatty Liver Disease Model
by: Sungmin Lee, et al.
Published: (2018-07-01)

Platinum–gold nanoraspberries as effective photosensitizer in anticancer photothermal therapy
by: J. Depciuch, et al.
Published: (2019-10-01)

H-Dot Mediated Nanotherapeutics Mitigate Systemic Toxicity of Platinum-Based Anticancer Drugs
by: Atsushi Yamashita, et al.
Published: (2023-10-01)

The Drug-Resistance Mechanisms of Five Platinum-Based Antitumor Agents
by: Jiabei Zhou, et al.
Published: (2020-03-01)

A Molecular Study on Drug Delivery System Based on Carbon Nanotube Compared to Silicon Carbide Nanotube for Encapsulation of Platinum-Based Anticancer Drug
by: Zahra Khatti, et al.
Published: (2018-03-01)

Simple <i>Trans</i>-Platinum Complex Bearing 3-Aminoflavone Ligand Could Be a Useful Drug: Structure-Activity Relationship of Platinum Complex in Comparison with Cisplatin
by: Małgorzata Fabijańska, et al.
Published: (2020-03-01)

Nanoarchitectonics: Complexes and Conjugates of Platinum Drugs with Silicon Containing Nanocarriers. An Overview
by: Kinga Piorecka, et al.
Published: (2021-08-01)

Downregulated CLIP3 induces radioresistance by enhancing stemness and glycolytic flux in glioblastoma
by: Hyunkoo Kang, et al.
Published: (2021-09-01)

Ligand Evolution in the Photoactivatable Platinum(IV) Anticancer Prodrugs
by: Jingjing Huang, et al.
Published: (2022-06-01)

Hybrid Drugs—A Strategy for Overcoming Anticancer Drug Resistance?
by: Marta Szumilak, et al.
Published: (2021-04-01)

Novel platinum–palladium bimetallic nanoparticles synthesized by Dioscorea bulbifera: anticancer and antioxidant activities
by: Ghosh S, et al.
Published: (2015-12-01)

Synthesis and Characterisation of Fluorescent Novel Pt(II) Cyclometallated Complexes with Anticancer Activity
by: Brondwyn S. McGhie, et al.
Published: (2023-04-01)

Synthesis, Characterization, and Anticancer Activity of Benzothiazole Aniline Derivatives and Their Platinum (II) Complexes as New Chemotherapy Agents
by: Md. Kamrul Islam, et al.
Published: (2021-08-01)

Targeting Glioblastoma Stem Cells to Overcome Chemoresistance: An Overview of Current Therapeutic Strategies
by: Hyunkoo Kang, et al.
Published: (2022-06-01)

Protein Binding of a Novel Platinum-Based Anticancer Agent BP-C1 Containing a Lignin-Derived Polymeric Ligand
by: Elena Fedoros, et al.
Published: (2021-11-01)

Anticancer platinum-drug delivered by mesenchymal stromal cells improves its activity on glioblastoma
by: Valentina Coccè, et al.
Published: (2024-01-01)

Peptides to Overcome the Limitations of Current Anticancer and Antimicrobial Nanotherapies
by: Valentina Del Genio, et al.
Published: (2022-06-01)

Dual Specificity Kinase DYRK3 Promotes Aggressiveness of Glioblastoma by Altering Mitochondrial Morphology and Function
by: Kyeongmin Kim, et al.
Published: (2021-03-01)

Oxidation of the Platinum(II) Anticancer Agent [Pt{(<i>p</i>-BrC<sub>6</sub>F<sub>4</sub>)NCH<sub>2</sub>CH<sub>2</sub>NEt<sub>2</sub>}Cl(py)] to Platinum(IV) Complexes by Hydrogen Peroxide
by: Ruchika Ojha, et al.
Published: (2023-09-01)

Nanocarriers for platinum drug delivery
by: Qingfei Zhang, et al.
Published: (2023-06-01)

Overcoming therapeutic resistance to platinum-based drugs by targeting Epithelial–Mesenchymal transition
by: Xirui Duan, et al.
Published: (2022-10-01)

Ovarian Cancer—Insights into Platinum Resistance and Overcoming It
by: Andrei Havasi, et al.
Published: (2023-03-01)

Natural Based Anticancer Drugs and Their Worthiness
by: Kamran Hajinabi
Published: (2017-02-01)

Platinum(IV) Complexes of <i>trans</i>-1,2-diamino-4-cyclohexene: Prodrugs Affording an Oxaliplatin Analogue that Overcomes Cancer Resistance
by: Paride Papadia, et al.
Published: (2020-03-01)

Older but Stronger: Development of Platinum-Based Antitumor Agents and Research Advances in Tumor Immunity
by: Jianing Liu, et al.
Published: (2023-03-01)

Exploring the Impact of Head Group Modifications on the Anticancer Activities of Fatty-Acid-like Platinum(IV) Prodrugs: A Structure–Activity Relationship Study
by: Man Kshetri, et al.
Published: (2023-08-01)

Nanomaterial‐mediated platinum drug‐based combinatorial cancer therapy
by: Zhiqin Deng, et al.
Published: (2021-02-01)

Biosynthesis of palladium, platinum, and their bimetallic nanoparticles using rosemary and ginseng herbal plants: evaluation of anticancer activity
by: Moloud Alinaghi, et al.
Published: (2024-03-01)

Platinum-Based Nanoformulations for Glioblastoma Treatment: The Resurgence of Platinum Drugs?
by: Paula Alfonso-Triguero, et al.
Published: (2023-05-01)